QUDEXY XR (TOPIRAMATE) — FDA Approval NDA205122 (UPSHER SMITH LABS)
QUDEXY XR (TOPIRAMATE) — FDA Approval NDA205122 (UPSHER SMITH LABS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: QUDEXY XR; Active ingredients: TOPIRAMATE; Application number: NDA205122.
| Brand name | QUDEXY XR |
|---|---|
| Active ingredients | TOPIRAMATE |
| Application number | NDA205122 |
| Sponsor | UPSHER SMITH LABS |
| Dosage form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 5 |
| First approval date | 20140311 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →